Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Hematology | Devices
Disease Category: Hemodialysis
Location: United States, NY
End-stage Renal Disease Hemodialysis
The purpose of this study is to test a new liquid drug (during the dialysis procedure) containing iron that may help maintain your iron storage ability for people who are on chronic hemodialysis for end-stage renal disease.
Study drug and study procedures will be made available to you at no cost.
To qualify, you must:
You will not qualify if you:
CW ID: 134393
Date Last Changed:
July 25, 2013
Susan Mathew, Research CoordinatorBiomedical Research Alliance of New YorkNorth Shore University Hospital
100 Community Drive - 2nd FloorGreat Neck, NY 11021Phone: 516-465-8200
Biomedical Research Alliance of New York
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
We value your privacy and your information will only be used by the research center to contact
you regarding this study.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2015 CenterWatch.